Theralink Technologies (THER) Financial Statements
Theralink Technologies Financial Overview
Theralink Technologies's market cap is currently $6.15K. The company's EPS TTM is $-0.02; its P/E ratio is 0.00; Theralink Technologies is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Sep 23 | Sep 22 | Sep 21 | Sep 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 606.80K | $ 567.90K | $ 505.60K | $ 181.23K | $ 0.00 |
| Gross Profit | $ 480.56K | $ 343.02K | $ 388.15K | $ 128.64K | $ 0.00 |
| Operating Income | $ -8.98M | $ -11.64M | $ -5.57M | $ -3.36M | $ -1.77M |
| EBITDA | $ -8.73M | $ -11.45M | $ -5.38M | $ -3.26M | $ -1.77M |
| Net Income | $ -30.91M | $ -12.75M | $ -5.59M | $ -3.21M | $ -11.20M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 998.28K | $ 397.16K | $ 325.15K | $ 1.79M | $ 21.49K |
| Total Assets | $ 2.85M | $ 2.60M | $ 1.64M | $ 3.20M | $ 94.20K |
| Total Debt | $ 19.76M | $ 4.37M | $ 478.99K | $ 392.19K | $ 3.48M |
| Net Debt | $ 18.76M | $ 3.98M | $ 164.84K | $ -1.39M | $ 3.46M |
| Total Liabilities | $ 40.97M | $ 6.40M | $ 3.58M | $ 1.50M | $ 16.03M |
| Stockholders' Equity | $ -38.12M | $ -3.80M | $ -1.95M | $ 1.69M | $ -15.94M |
| Cash Flow | |||||
| Free Cash Flow | $ -5.94M | $ -5.52M | $ -4.92M | $ -4.00M | $ -1.17M |
| Operating Cash Flow | $ -5.77M | $ -5.39M | $ -4.78M | $ -3.47M | $ -1.17M |
| Investing Cash Flow | $ -163.38K | $ -131.61K | $ -134.20K | $ 144.39K | $ 0.00 |
| Financing Cash Flow | $ 6.54M | $ 5.60M | $ 3.45M | $ 4.55M | $ 1.19M |
Currency in USD